• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Research Ethics in the Context of Transition: Gaps in Policies and Programs on the Protection of Research Participants in the Selected Countries of Central and Eastern Europe.转型背景下的研究伦理:中东欧选定国家在研究参与者保护政策与项目方面的差距
Sci Eng Ethics. 2016 Dec;22(6):1689-1706. doi: 10.1007/s11948-015-9723-4. Epub 2015 Nov 9.
2
Colorectal cancer prevention in Central, Eastern European and South Caucasus countries: a review of policy approaches.中、东欧和南高加索国家的结直肠癌预防:政策方法综述。
J Health Organ Manag. 2024 May 28;ahead-of-print(ahead-of-print). doi: 10.1108/JHOM-02-2023-0030.
3
Research ethics review: identifying public policy and program gaps.研究伦理审查:识别公共政策与项目差距。
J Empir Res Hum Res Ethics. 2014 Apr;9(2):3-11. doi: 10.1525/jer.2014.9.2.3.
4
Building research ethics capacity in post-communist countries: experience of two Fogarty training programs.在后共产主义国家建设研究伦理能力:两项福格蒂培训项目的经验
J Empir Res Hum Res Ethics. 2013 Dec;8(5):28-39. doi: 10.1525/jer.2013.8.5.28.
5
Antecedents of use of e-health services in Central Eastern Europe: a qualitative comparative analysis.中东欧电子健康服务使用的前因:定性比较分析。
BMC Health Serv Res. 2020 Mar 4;20(1):171. doi: 10.1186/s12913-020-5034-9.
6
Clinical Ethics Consultation in the Transition Countries of Central and Eastern Europe.中东欧转型国家的临床伦理咨询。
Sci Eng Ethics. 2020 Apr;26(2):833-850. doi: 10.1007/s11948-019-00141-z. Epub 2019 Oct 5.
7
Burden of varicella in Central and Eastern Europe: findings from a systematic literature review.中东欧水痘负担:系统文献回顾的结果。
Expert Rev Vaccines. 2019 Mar;18(3):281-293. doi: 10.1080/14760584.2019.1573145. Epub 2019 Feb 27.
8
Factors Influencing Health Care Providers Payment Reforms in Central and Eastern European Countries.影响中东欧国家医疗保健提供者支付改革的因素。
Inquiry. 2024 Jan-Dec;61:469580241287626. doi: 10.1177/00469580241287626.
9
The evolution of the health system outcomes in Central and Eastern Europe and their association with social, economic and political factors: an analysis of 25 years of transition.中东欧卫生系统成果的演变及其与社会、经济和政治因素的关联:25年转型期分析
BMC Health Serv Res. 2016 Mar 17;16:95. doi: 10.1186/s12913-016-1344-3.
10
Establishment and work of ethics committees in central and eastern European countries.中东欧国家伦理委员会的设立与工作。
Med Etika Bioet. 2002 Spring-Summer;9(1-2):9-12.

引用本文的文献

1
Developing Quality and Efficiency of Institutional Review Board Review Under a Human Research Protection Program at a Leading Hospital in Central Southern China: A Descriptive Analysis of the First Three Years.中国中南部一家顶尖医院的人类研究保护计划下机构审查委员会审查的质量与效率提升:头三年的描述性分析
J Empir Res Hum Res Ethics. 2021 Jul;16(3):280-289. doi: 10.1177/1556264621995656. Epub 2021 Mar 17.
2
Research ethics review: identifying public policy and program gaps.研究伦理审查:识别公共政策与项目差距。
J Empir Res Hum Res Ethics. 2014 Apr;9(2):3-11. doi: 10.1525/jer.2014.9.2.3.

本文引用的文献

1
Research ethics review: identifying public policy and program gaps.研究伦理审查:识别公共政策与项目差距。
J Empir Res Hum Res Ethics. 2014 Apr;9(2):3-11. doi: 10.1525/jer.2014.9.2.3.
2
Failures in clinical trials in the European Union: lessons from the Polish experience.欧盟临床试验失败:波兰经验教训。
Sci Eng Ethics. 2013 Sep;19(3):1087-98. doi: 10.1007/s11948-012-9400-9. Epub 2012 Oct 6.
3
ETHICAL REVIEW OF BIOMEDICAL RESEARCH IN BELARUS: CURRENT STATUS, PROBLEMS AND PERSPECTIVES.白俄罗斯生物医学研究的伦理审查:现状、问题与展望
Rev Rom Bioet. 2011 Apr;9(2):74-83.
4
Why (not) go east? Comparison of findings from FDA Investigational New Drug study site inspections performed in Central and Eastern Europe with results from the USA, Western Europe, and other parts of the world.为什么(不)往东走?美国食品药品监督管理局(FDA)对中东欧地区开展的研究性新药研究场所检查结果与美国、西欧及世界其他地区的检查结果对比
Drug Des Devel Ther. 2012;6:53-60. doi: 10.2147/DDDT.S30109. Epub 2012 Mar 27.
5
Twenty years of human research ethics committees in the Baltic States.波罗的海国家 20 年的人类研究伦理委员会。
Dev World Bioeth. 2011 Apr;11(1):48-54. doi: 10.1111/j.1471-8847.2010.00288.x. Epub 2010 Dec 7.
6
A comparative analysis of biomedical research ethics regulation systems in Europe and Latin America with regard to the protection of human subjects.比较分析欧洲和拉丁美洲的生物医学研究伦理规范体系,探讨其在保护人类受试者方面的差异。
J Med Ethics. 2010 Dec;36(12):750-3. doi: 10.1136/jme.2009.035097. Epub 2010 Aug 26.
7
Non-equivalent stringency of ethical review in the Baltic States: a sign of a systematic problem in Europe?波罗的海国家伦理审查的宽松程度不同:这是欧洲系统性问题的迹象吗?
J Med Ethics. 2010 Jul;36(7):435-9. doi: 10.1136/jme.2009.035030.
8
Health reform in central and eastern Europe and the former Soviet Union.中东欧及前苏联地区的医疗改革。
Lancet. 2009 Oct 3;374(9696):1186-95. doi: 10.1016/S0140-6736(09)61334-9.
9
Moving from research ethics review to research ethics systems in low-income and middle-income countries.从低收入和中等收入国家的研究伦理审查转向研究伦理体系
Lancet. 2009 Mar 7;373(9666):862-5. doi: 10.1016/S0140-6736(09)60488-8.
10
Polish Research Ethics Committees in the European Union system of assessing medical experiments.欧盟医学实验评估体系中的波兰研究伦理委员会。
Sci Eng Ethics. 2009 Jun;15(2):201-12. doi: 10.1007/s11948-009-9113-x. Epub 2009 Jan 21.

转型背景下的研究伦理:中东欧选定国家在研究参与者保护政策与项目方面的差距

Research Ethics in the Context of Transition: Gaps in Policies and Programs on the Protection of Research Participants in the Selected Countries of Central and Eastern Europe.

作者信息

Famenka Andrei

机构信息

State Service of Legal Medicine, Dolgobrodskaya Street, 6-2-23, Minsk, Belarus.

出版信息

Sci Eng Ethics. 2016 Dec;22(6):1689-1706. doi: 10.1007/s11948-015-9723-4. Epub 2015 Nov 9.

DOI:10.1007/s11948-015-9723-4
PMID:26548313
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4861682/
Abstract

This paper examines the ability of countries in Central and Eastern Europe (CEE) to ensure appropriate protection of research participants in the field of increasingly globalizing biomedical research. By applying an analytical framework for identifying gaps in policies and programs for human subjects protection to four countries of CEE-Belarus, Latvia, Lithuania, and Poland, substantial gaps in the scope and content of relevant policies and major impediments to program performance have been revealed. In these countries, public policies on the protection of research participants lack consistency and reliable mechanisms for their implementation. Impediments to program performance most often relate to inadequacies in the national research ethics systems with regard to organizational structure, budgetary support, supervision, and training. The level of research ethics capacity varies from country to country and depends on socio-economic and political factors of post-communist transition. The breadth and depth of the problems identified suggest that the current level of protection for research participants in CEE might be inadequate to the challenges posed by the globalization of biomedical research. In CEE countries, there is a need for strengthening research ethics capacity through modification of relevant policies and improvement of program management. The differences among the countries call for further research on identifying the best approaches for filling the gaps in the policies and programs aimed at ensuring effective protection of research participants.

摘要

本文探讨了中东欧国家在日益全球化的生物医学研究领域确保适当保护研究参与者的能力。通过将用于识别保护人类受试者的政策和计划中差距的分析框架应用于中东欧的四个国家——白俄罗斯、拉脱维亚、立陶宛和波兰,揭示了相关政策在范围和内容上的重大差距以及计划实施的主要障碍。在这些国家,关于保护研究参与者的公共政策缺乏一致性以及可靠的实施机制。计划实施的障碍最常与国家研究伦理体系在组织结构、预算支持、监督和培训方面的不足有关。研究伦理能力水平因国家而异,并取决于后共产主义转型的社会经济和政治因素。所发现问题的广度和深度表明,中东欧目前对研究参与者的保护水平可能不足以应对生物医学研究全球化带来的挑战。在中东欧国家,需要通过修改相关政策和改进计划管理来加强研究伦理能力。各国之间的差异要求进一步研究,以确定填补旨在确保有效保护研究参与者的政策和计划差距的最佳方法。